Mingyang Li1, Xueyan Li1, Yu Guo2, Zheng Miao1, Xiaoming Liu1, Shuxu Guo1, Huimao Zhang2. 1. State Key Laboratory on Integrated Optoelectronics, College of Electronic Science and Engineering, Jilin University, Changchun 130012, China. 2. Department of Radiology, the First Hospital of Jilin University, Changchun 130021, China.
Abstract
BACKGROUND: This article aims to develop and assess the radiomics paradigm for predicting colorectal cancer liver metastasis (CRLM) from the primary tumor. METHODS: This retrospective study included 100 patients from the First Hospital of Jilin University from June 2017 to December 2017. The 100 patients comprised 50 patients with and 50 without CRLM. The maximum-level enhanced computed tomography (CT) image of primary cancer in the portal venous phase of each patient was selected as the original image data. To automatically implement radiomics-related paradigms, we developed a toolkit called Radiomics Intelligent Analysis Toolkit (RIAT). RESULTS: With RIAT, the model based on logistic regression (LR) using both the radiomics and clinical information signatures showed the maximum net benefit. The area under the curve (AUC) value was 0.90±0.02 (sensitivity =0.85±0.02, specificity =0.79±0.04) for the training set, 0.86±0.11 (sensitivity =0.85±0.09, specificity =0.75±0.19) for the verification set, 0.906 (95% CI, 0.840-0.971; sensitivity =0.81, specificity =0.84) for the cross-validation set, and 0.899 (95% CI, 0.761-1.000; sensitivity =0.78, specificity =0.91) for the test set. CONCLUSIONS: The radiomics nomogram-based LR with clinical risk and radiomics features allows for a more accurate classification of CRLM using CT images with RIAT. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.
BACKGROUND: This article aims to develop and assess the radiomics paradigm for predicting colorectal cancer liver metastasis (CRLM) from the primary tumor. METHODS: This retrospective study included 100 patients from the First Hospital of Jilin University from June 2017 to December 2017. The 100 patients comprised 50 patients with and 50 without CRLM. The maximum-level enhanced computed tomography (CT) image of primary cancer in the portal venous phase of each patient was selected as the original image data. To automatically implement radiomics-related paradigms, we developed a toolkit called Radiomics Intelligent Analysis Toolkit (RIAT). RESULTS: With RIAT, the model based on logistic regression (LR) using both the radiomics and clinical information signatures showed the maximum net benefit. The area under the curve (AUC) value was 0.90±0.02 (sensitivity =0.85±0.02, specificity =0.79±0.04) for the training set, 0.86±0.11 (sensitivity =0.85±0.09, specificity =0.75±0.19) for the verification set, 0.906 (95% CI, 0.840-0.971; sensitivity =0.81, specificity =0.84) for the cross-validation set, and 0.899 (95% CI, 0.761-1.000; sensitivity =0.78, specificity =0.91) for the test set. CONCLUSIONS: The radiomics nomogram-based LR with clinical risk and radiomics features allows for a more accurate classification of CRLM using CT images with RIAT. 2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.
Entities:
Keywords:
Radiomics; colorectal cancer liver metastasis (CRLM); machine learning; nomogram
Authors: D Pinto Dos Santos; D Giese; S Brodehl; S H Chon; W Staab; R Kleinert; D Maintz; B Baeßler Journal: Eur Radiol Date: 2018-07-06 Impact factor: 5.315
Authors: Chintan Parmar; Emmanuel Rios Velazquez; Ralph Leijenaar; Mohammed Jermoumi; Sara Carvalho; Raymond H Mak; Sushmita Mitra; B Uma Shankar; Ron Kikinis; Benjamin Haibe-Kains; Philippe Lambin; Hugo J W L Aerts Journal: PLoS One Date: 2014-07-15 Impact factor: 3.240
Authors: Nathaniel M Braman; Maryam Etesami; Prateek Prasanna; Christina Dubchuk; Hannah Gilmore; Pallavi Tiwari; Donna Plecha; Anant Madabhushi Journal: Breast Cancer Res Date: 2017-05-18 Impact factor: 6.466
Authors: A Akilandeswari; D Sungeetha; Christeena Joseph; K Thaiyalnayaki; K Baskaran; R Jothi Ramalingam; Hamad Al-Lohedan; Dhaifallah M Al-Dhayan; Muthusamy Karnan; Kibrom Meansbo Hadish Journal: Evid Based Complement Alternat Med Date: 2022-03-17 Impact factor: 2.629